Patterns of antenatal corticosteroid prescribing 1998-2004

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 47, Issue 1, 2007, Pages 42-45

  Polyakov, Alex ^a   Cohen, Saul ^a   Baum, Marita ^a   Trickey, Donna ^a   Jolley, Damien ^a   Wallace, Euan M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antenatal care; Corticosteroids; Pregnancy; Preterm birth

Indexed keywords

CORTICOSTEROID;

ARTICLE; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; DRUG EXPOSURE; ELECTRONIC MEDICAL RECORD; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; PREGNANCY; PRENATAL PERIOD; PRESCRIPTION; PRIORITY JOURNAL;

AUSTRALIA; DRUG UTILIZATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; OBSTETRIC LABOR, PREMATURE; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PRENATAL CARE; RETROSPECTIVE STUDIES;

EID: 33846516936     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2006.00677.x     Document Type: Article

References (15)

1. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Libr 2003; 2: CD000065.
2. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal steroid administration on the infant: Long-term follow-up. J Pediatr 1984; 104: 259-267.
3. Dalziel SR, Lim VK, Lambert A et al. Antenatal exposure to betamethasone. psychological functioning and health related quality of life 31 years after inclusion in a randomised controlled trial. BMJ 2005; 331: 655-658.
4. Dalziel SR, Walker NK, Parag Mantell C, Rea HH, Rodgers A, Harding JE. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005; 365: 1856-1862.
5. National Institutes of Health. Report of the Consensus Development Conference on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcome. NIH publication no. 95-3784. Bethesda, MD: National Institute of Child Health and Human Development, November 1994.
6. Scientific Advisory Committee of the Royal College of Obstetricians and Gynaecologists. RCOG Guidelines No.7: Antenatal Corticosteroids to Prevent Respiratory Distress Syndrome. London: RCOG, 1996.
7. Department of Human Services, Victorian Government. Measuring Maternity Care. The Final Set of Performance Indicators 2002. [Cited 20 November 2006] Available from http://www.health.vic.gov.au/maternitycare/.
8. Lawson EE. Antenatal corticosteroids - too much of a good thing? JAMA 2001; 286: 1628-1630.
9. Newnham JP, Moss TJM, Nitsos I, Sloboda DM. Antenatal corticosteroids: The good, the bad and the unknown. Curr Opin Obstet Gynecol 2002; 14: 607-612.
10. Steer P. Giving steroids before elective caesarean section. BMJ 2005; 331: 645-646.
11. Wallace EM, Chapman J, Stenson B, Wright S. Antenatal corticosteroid prescribing. setting standards of care. Br J Obstet Gynaecol 1997; 104: 1262-1266.
12. Montan S, Arulkumaran S. Neonatal respiratory distress syndrome. Lancet 2006; 367: 1878-1879.
13. Davis EP, Townsend EL, Gunnar MR et al. Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants. Psychoneuroendocrinology 2004; 29: 1028-1036.
14. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 2000; 98: 137-142.
15. Kay HH, Bird IM, Coe CL, Dudley DJ. Antenatal steroid treatment and adverse fetal effects: What is the evidence? J Soc Gynecol Invest 2000; 7: 269-278.